An innovative joint venture between the state and the private sector
On December 15th 2005, the Spanish Prime Minister presided at the creation of the Pro CNIC Foundation, through which some of the most important Spanish companies have agreed to provide a significant part of the funding for the research activity at the Centro Nacional de Investigaciones Cardiovasculares (CNIC).
Through the creation of the Pro CNIC Foundation, some of the largest companies in the country have made a long-term commitment to biomedical research.
One of the central elements of the agreement was the incorporation of Valentín Fuster as president of the center’s External Scientific Advisory and Evaluation Committee. The creation of the Pro CNIC Foundation represents the most significant act of business sponsorship in recent years in terms of the amount of funding it provides, its social significance, the group of companies involved, and the anticipated outcomes.
Participating companies take part in important decisions about the CNIC’s activities through their representation on the CNIC’s Board of Trustees. The CNIC project is thus structured as a joint venture between the state and the private sector, ensuring stable funding.
If you would like to read more about funding at the CNIC please download the following article published at Nature Clinical Practice Cardiovascular Medicine Nature Clinical Practice Cardiovascular CNIC Edition (November 2008 | Vol 5 | N.º 11 | CNIC-2)
Accreditation of the CNIC as a Severo Ochoa 2020 Center of Excellence
Among all the competitive projects funded through public calls for proposals, the Severo Ochoa Program stands out for its objective of supporting competitive scientific research carried out in Spain, identifying and promoting research centers that have positioned themselves among the best in the world in their respective areas.
The new CNIC Severo Ochoa accreditation (2022-2025) enables us to advance our knowledge of the principles underlying cardiovascular homeostasis, and to work on the prevention and treatment of atherosclerosis, myocardial diseases and arrhythmogenic disorders. The execution of this project will reinforce the CNIC's leadership in basic and translational research, including a significant increase in leadership in the coordination and execution of clinical trials that modify clinical practice.
Grant CEX2020-001041-S funded by MCIN/AEI /10.13039/501100011033.
Start date: 01/01/2022
End date: 31/12/2025
Budget: 4.000.000 euros
Call: Centros de Excelencia «Severo Ochoa» y Unidades de Excelencia «María de Maeztu» 2020
Other useful links: